Embracing cancer immunotherapy with vital micronutrients

Volume: 12, Issue: 9, Pages: 712 - 724
Published: Sep 24, 2021
Abstract
Immunotherapy is now commonly prescribed to cancer patients, but autoimmune-related adverse events are considerable. For severe, life-threatening side effects, cessation of therapy seems unavoidable, let alone intensive medical care required for patching up the adverse events. Even without serious adverse events, the response rates are too low and various combinatory regimens have been tried. However, toxicities are also added on, unless the...
Paper Details
Title
Embracing cancer immunotherapy with vital micronutrients
Published Date
Sep 24, 2021
Volume
12
Issue
9
Pages
712 - 724
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.